Strata Oncology logo

Strata Oncology

Strata Oncology is improving enrollment in precision oncology clinical trials by providing genetic sequencing for late-stage cancer patients.

strataoncology.com
Ann Arbor, MI

CEO: Dan Rhodes
Arboretum Lead: Jan Garfinkle

IN THE NEWS
September 14, 2022 in Strata Oncology

Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer

Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced expansion of its clinical collaboration with Pfizer ( NYSE: PFE) in the Strata Precision Indications for Approved THerapies (Strata PATHTM) trial.
Read More
August 16, 2022 in News Page, Strata Oncology

Strata Oncology Expands Strata PATH Trial to Eight Sarah Cannon Research Institute Sites

Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced that Sarah Cannon Research Institute (SCRI) has joined the Strata Precision Indications for Approved THerapies (Strata PATH™) trial.
Read More